Toronto Dominion Bank
RVPHW

Toronto Dominion Bank’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Toronto Dominion Bank’s Portfolio RVPHW Stock Details RVPHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$3 – 2075
2025
Q2 		$3 Buy
+100
New +$5 ﹤0.01% 1788

Other funds holding RVPHW

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Toronto Dominion Bank's RVPHW Position: Q3 2025 in Review

Toronto Dominion Bank sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q3 2025, closing a stake of 100 shares — an estimated $3 sold.

Toronto Dominion Bank first reported a position in RVPHW in Q2 2025 and held it in 1 quarter. The position peaked at $3 in Q2 2025. 2 funds tracked by Wall St. Rank hold RVPHW as of Q3 2025.

  • Toronto Dominion Bank reported no remaining Reviva Pharmaceuticals Warrants position as of Q3 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 100 Reviva Pharmaceuticals Warrants shares in Q3 2025, an estimated $3.
  • Toronto Dominion Bank first reported a position in Reviva Pharmaceuticals Warrants in Q2 2025 and held it in 1 quarter.
  • Toronto Dominion Bank's Reviva Pharmaceuticals Warrants position peaked at $3 in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q3 2025.

Based on Toronto Dominion Bank's 13F filing for Q3 2025, filed 14 Nov 2025.